FTC sues main pharmacy benefit managers over insulin price ranges The agency brought motion versus Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of daily life-conserving insulin medicines. This strategy aligns with Those people initiatives, the ONC claimed. The industry https://daveshotchickennutrition49494.spintheblog.com/31020373/considerations-to-know-about-healthcare-news